CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −5,300 | 66,105 | ||
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +5,300 | $0.30 | $2K | 91,000 |
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Sale | −1,417 | $61.37 | $87K | 89,583 |
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Sale | −1,009 | $62.32 | $63K | 88,574 |
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Sale | −2,315 | $63.50 | $147K | 86,259 |
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Sale | −559 | $64.15 | $36K | 85,700 |
| 2022-04-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −5,300 | 71,405 | ||
| 2022-04-06 | Rovaldi Christopher Chief Operating Officer | Exercise or conversion | +1,728 | $16.00 | $28K | 1,728 |
| 2022-04-06 | Rovaldi Christopher Chief Operating Officer | Sale | −1,728 | $65.00 | $112K | 0 |
| 2022-04-06 | Rovaldi Christopher Chief Operating Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,728 | 8,002 | ||
| 2022-04-04 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +7,950 | $0.30 | $2K | 93,650 |
| 2022-04-04 | Lachey Jennifer Chief Scientific Officer | Sale | −7,950 | $60.00 | $477K | 85,700 |
| 2022-04-04 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · of Shares Employee Stock Option (right to buy) | −7,950 | 76,705 | ||
| 2022-04-01 | Rovaldi Christopher Chief Operating Officer | Exercise or conversion | +864 | $16.00 | $14K | 864 |
| 2022-04-01 | Rovaldi Christopher Chief Operating Officer | Sale | −2 | $54.34 | $109 | 862 |
| 2022-04-01 | Rovaldi Christopher Chief Operating Officer | Sale | −104 | $56.20 | $6K | 758 |
| 2022-04-01 | Rovaldi Christopher Chief Operating Officer | Sale | −287 | $56.89 | $16K | 471 |
| 2022-04-01 | Rovaldi Christopher Chief Operating Officer | Sale | −366 | $57.97 | $21K | 105 |
| 2022-04-01 | Rovaldi Christopher Chief Operating Officer | Sale | −105 | $58.83 | $6K | 0 |
| 2022-04-01 | Rovaldi Christopher Chief Operating Officer | Exercise or conversion · Employee Stock Option (right to buy) | −864 | 9,730 |
Page 10 of 36 · 707 trades